PYROLATE INJ 0.2MG IV

Pyrolate 0.2mg Injection IV – Glycopyrrolate for Preoperative and Anesthesia Use

Pyrolate 0.2mg Injection is a sterile intravenous (IV) solution containing Glycopyrrolate 0.2mg, an anticholinergic agent used to reduce salivary, bronchial, and gastric secretions during surgery and to prevent bradycardia during anesthesia. It is commonly administered preoperatively or intraoperatively in surgical settings.

Key Features:

• ✅ Contains Glycopyrrolate 0.2mg per dose

• ✅ Used to reduce secretions before or during surgery

• ✅ Helps prevent vagal reflexes (e.g., bradycardia) during anesthesia

• ✅ Fast-acting IV formulation for hospital and clinical use

• ✅ Commonly used in pre-anesthetic medication protocols

• ✅ Administered under strict medical supervision

Indications:

• Pre-anesthetic use to reduce oral and respiratory tract secretions

• Prevention or treatment of intraoperative bradycardia

• Used in combination with neostigmine to reverse neuromuscular blockade post-surgery

Directions for Use:

Administered intravenously (IV) by a qualified healthcare professional in a clinical or surgical setting. Dosage and timing depend on the patient’s age, weight, and clinical condition.

Important Notes:

• For hospital use only – not for self-administration

• Use with caution in patients with glaucoma, enlarged prostate, or heart disease

• May cause dry mouth, blurred vision, or dizziness